Follow
Breanne Sparta
Breanne Sparta
Verified email at ucla.edu
Title
Cited by
Cited by
Year
Receptor level mechanisms are required for epidermal growth factor (EGF)-stimulated extracellular signal-regulated kinase (ERK) activity pulses
B Sparta, M Pargett, M Minguet, K Distor, G Bell, JG Albeck
Journal of Biological Chemistry 290 (41), 24784-24792, 2015
932015
Relaxation oscillations and hierarchy of feedbacks in MAPK signaling
M Kochańczyk, P Kocieniewski, E Kozłowska, J Jaruszewicz-Błońska, ...
Scientific reports 7 (1), 38244, 2017
622017
Single-cell imaging of ERK signaling using fluorescent biosensors
M Pargett, TE Gillies, CK Teragawa, B Sparta, JG Albeck
Kinase Signaling Networks, 35-59, 2017
302017
Transient phases of OXPHOS inhibitor resistance reveal underlying metabolic heterogeneity in single cells
N Kosaisawe, B Sparta, M Pargett, CK Teragawa, JG Albeck
Cell metabolism 33 (3), 649-665. e8, 2021
232021
Continuous sensing of nutrients and growth factors by the mTORC1-TFEB axis
B Sparta, N Kosaisawe, M Pargett, M Patankar, N DeCuzzi, JG Albeck
Elife 12, e74903, 2023
22023
A lack of distinct cell identities in single-cell measurements: revisiting Waddington’s landscape
B Sparta, T Hamilton, S Hughes, EJ Deeds
bioRxiv, 2022.06. 03.494765, 2022
22022
Binomial models uncover biological variation during feature selection of droplet-based single-cell RNA sequencing
B Sparta, T Hamilton, SD Aragones, EJ Deeds
bioRxiv, 2021.07. 11.451989, 2021
22021
Abstract C169: MM-141, a bispecific antibody inhibitor of PI3K/AKT/mTOR, attenuates tumor growth and potentiates everolimus in mouse models of anti-hormonal therapy-resistant …
S Adams, J Baum, B Sparta, V Rimkunas, J Tang, E Pace, S Rosenthal, ...
Molecular Cancer Therapeutics 12 (11_Supplement), C169-C169, 2013
12013
Zebrafish: A predictive model for assessing seizure liability
D Park, J Meidenbauer, B Sparta, WL Seng, P McGrath
Zebrafish: Methods for Assessing Drug Safety and Toxicity, 165-175, 2011
12011
The system can't perform the operation now. Try again later.
Articles 1–9